ʻO ka PCR Fluorescence
-
18 Nā ʻano o ke kanaka papilloma virus nucleic acid kiʻekiʻe
He kūpono kēia pahu no ka ʻike in vitro qualitative o 18 mau ʻano o nā maʻi papilloma kanaka (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) nā ʻāpana nucleic acid kikoʻī i loko o ka mimi kāne / wahine a me nā pūnaewele exfoliated cervical wahine a me ka HPV 16/18 type.
-
Klebsiella Pneumoniae, Acinetobacter Baumannii a me Pseudomonas Aeruginosa a me Drug Resistance Genes (KPC, NDM, OXA48 a me IMP) Multiplex
Hoʻohana ʻia kēia kit no ka ʻike in vitro qualitative o Klebsiella pneumoniae (KPN), Acinetobacter baumannii (Aba), Pseudomonas aeruginosa (PA) a me ʻehā carbapenem resistance genes (ʻo ia hoʻi ʻo KPC, NDM, OXA48 a me IMP) i nā laʻana sputum kanaka, e hāʻawi. ke kumu o ke alakaʻi ʻana i ka maʻi maʻi, ka mālama ʻana a me ka lāʻau lapaʻau no nā maʻi i manaʻo ʻia he maʻi bacterial.
-
Mycoplasma Pneumoniae （MP）
Hoʻohana ʻia kēia huahana no ka ʻike in vitro qualitative o Mycoplasma pneumoniae (MP) nucleic acid i loko o ka sputum kanaka a me nā laʻana oropharyngeal swab.
-
Clostridium difficile toxin A/B gene（C.diff）
Hoʻolālā ʻia kēia pahu no ka ʻike in vitro qualitative o clostridium difficile toxin A gene a me toxin B gene i loko o nā laʻana stool mai nā mea maʻi i manaʻo ʻia i ka maʻi clostridium difficile.
-
ʻŌnaehana Kūʻē Carbapenem (KPC/NDM/OXA 48/OXA 23/VIM/IMP)
Hoʻohana ʻia kēia kit no ka ʻike qualitative o nā genes resistance carbapenem i nā ʻano sputum kanaka, rectal swab samples a i ʻole nā kolone maʻemaʻe, me KPC (Klebsiella pneumonia carbapenemase), NDM (New Delhi metallo-β-lactamase 1), OXA48 (oxacillinase 48), OXA23 (oxacillinase 23), VIM (Verona Imipenemase), a me IMP (Imipenemase).
-
Influenza A/B
Hoʻohana ʻia kēia kit no ka ʻike kūpono o ka maʻi maʻi A/B nucleic acid i loko o nā laʻana oropharyngeal swab kanaka in vitro.
-
Influenza A Virus Universal/H1/H3
Hoʻohana ʻia kēia pahu no ka ʻike kūpono o ka maʻi maʻi influenza A ʻano honua, ʻano H1 a me H3 ʻano nucleic acid i loko o nā laʻana swab nasopharyngeal kanaka.
-
ʻO Zaire Ebola Virus
He mea kūpono kēia kit no ka ʻike kūpono o Zaire Ebola virus nucleic acid i ka serum a i ʻole plasma samples o nā maʻi i manaʻo ʻia he maʻi Zaire Ebola (ZEBOV).
-
Adenovirus Universal
Hoʻohana ʻia kēia kit no ka ʻike qualitative o ka adenovirus nucleic acid i ka nasopharyngeal swab a me ka puʻu ʻāʻī.
-
4 Nā ʻano o nā maʻi hoʻomake hanu
Hoʻohana ʻia kēia pahu no ka ʻike qualitative o2019-nCoV, ka ma'i influenza A, ka ma'i ma'i influenza B a me ka ma'i ma'i hanu syncytial nucleic acidsi ke kanakaoropharyngeal swab samples.
-
19 Nā ʻano o ka maʻi maʻi koko
He kūpono ka pahu no ka ʻike qualitative o Pseudomonas aeruginosa (PA), Acinetobacter baumannii (ABA), Klebsiella pneumoniae (KPN), Escherichia coli (ECO), Staphylococcus aureus (SA), Enterobacter cloacae (ENC), Staphylococcus epidermidis
(STAE), Candida tropicalis (CTR), Candida krusei (CKR), Candida albicans (CA), Klebsiella
oxytoca (KLO), Serratia marcescens (SMS), Proteus mirabilis (PM), Streptococcus
pneumoniae (SP), Enterococcus faecalis (ENF), Enterococcus faecium (EFS), Candida
parapsilosis (CPA), Candida glabrata (CG) a me Group B Streptococci (GBS) nucleic acids i loko o nā laʻana koko holoʻokoʻa.
-
12 Nā ʻano o ka maʻi maʻi hanu
Hoʻohana ʻia kēia kit no ka hui ʻana o ka qualitative detection o SARS-CoV-2, influenza A virus, influenza B virus, adenovirus, mycoplasma pneumoniae, rhinovirus, respiratory syncytial virus a me parainfluenza virus (Ⅰ, II, III, IV) a me metapneumovirus kanaka i loko. oropharyngeal swabs.
